Alnylam Pharmaceuticals Inc
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for Alnylam Pharmaceuticals Inc Note 0 09/15, CUSIP 02043QAC1.
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for Alnylam Pharmaceuticals Inc Note 0 09/15, CUSIP 02043QAC1.